Icell Gene Therapeutics
Clinical trials sponsored by Icell Gene Therapeutics, explained in plain language.
-
Engineered immune cells aim to tame stubborn IBD
Disease control Not yet recruitingThis early-phase study tests a new treatment called ICG318 CAR-T for people with inflammatory bowel disease (IBD) that hasn't improved with standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target and calm the overactive immune response cau…
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Engineered immune cells target lupus in early trial
Disease control Not yet recruitingThis study tests a new treatment called BCMA-CD19-IL-15 cCAR T cells for people with severe lupus that hasn't responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to attack lupus-causing cells. The goal is to see if it is safe and ca…
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC